Earnings History Data for Lumos Pharma, Inc. (LUMO) - NYSE NASDAQ
To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.
For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.
For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.
See the full list of available companies here.
Lumos Pharma, Inc.
Lumos Pharma Inc. is a clinical stage biopharmaceutical company. It is focused on the development and commercialization of therapeutics for rare and neglected diseases. The company's product pipeline consists of LUM-201 which is in clinical stage. Lumos Pharma Inc., formerly known as NewLink Genetics Corporation, is based in AUSTIN, Texas.
| Release Date | Time | Est. Time | Symbol | Name | Market Cap (M) | Rep. EPS | Est. EPS | Last years EPS | SeekingAlpha Headline | Price | Change | Ext. Hours Price | Ext. Hours Change | 52 Week Range | Volume | Avg. Volume | Ext. Hours Volume | Top Mover |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 07-03-2024 | AH | LUMO | Lumos Pharma, Inc. | 24.14 | -1.17 | -1.18 | -0.98 | Lumos Pharma GAAP EPS of -$4.18 misses by $0.13, revenue of $2.05M beats by $0.83M [3/7/2024 4:32 PM] |
3.06 | 0.04 (1.16%) |
3.05 | 0.02 (0.66%) |
2.63 - 4.55 | 120,641 | 20,000 | 9,616 | ||
| 07-11-2023 | AH | LUMO | Lumos Pharma | 28.00 | -1.04 | -1.10 | 0.00 | Lumos Pharma GAAP EPS of -$1.04 beats by $0.11, revenue of $7K [11/7/2023 5:22 PM] |
3.99 | 0.35 (9.62%) |
4.42 | 0.78 (21.43%) |
2.63 - 9.15 | 2,235,719 | 250,000 | 1,893,491 | ||
| 09-08-2023 | AH | LUMO | Lumos Pharma, Inc. | 25.49 | -1.09 | -1.06 | -0.94 | Lumos Pharma GAAP EPS of -$1.09 misses by $0.02, revenue of $0.53M beats by $0.33M [8/9/2023 4:37 PM] |
2.86 | -0.14 (-4.63%) |
0.0 | 0.0 (0.00%) |
2.80 - 9.56 | 40,041 | 20,000 | 0 | ||
| 03-05-2023 | AH | After the close (May 3) |
LUMO | Lumos Pharma, Inc. | 24.76 | -0.89 | -1.12 | -0.92 | Lumos Pharma GAAP EPS of -$0.89 beats by $0.24, revenue of $0.69M beats by $0.57M [5/3/2023 5:20 PM] |
3.60 | 0.30 (9.09%) |
0.0 | 0.0 (0.00%) |
2.95 - 9.56 | 8,467 | 10,000 | 0 | |
| 01-03-2023 | AH | After the close (Mar 1) |
LUMO | Lumos Pharma, Inc. | 28.23 | -0.98 | -0.95 | -0.68 | Lumos Pharma GAAP EPS of -$3.71 misses by $0.07, revenue of $1.52M beats by $0.38M [3/1/2023 4:30 PM] |
3.36 | -0.10 (-2.89%) |
0.0 | 0.0 (0.00%) |
2.95 - 10.17 | 12,842 | 10,000 | 0 | |
| 14-11-2022 | PM | Before the open (Nov 14) |
LUMO | Lumos Pharma | 76.00 | -0.86 | -1.01 | 0.00 | Lumos Pharma GAAP EPS of -$0.86 beats by $0.15, revenue of $0.49M [11/14/2022 6:27 AM] |
5.90 | -3.01 (-33.74%) |
0.0 | 0.0 (0.00%) |
5.90 - 10.27 | 123,039 | 10,000 | 0 | |
| 09-08-2022 | AH | 4:00 PM ET (Aug 9) |
LUMO | Lumos Pharma, Inc. | 65.77 | -0.94 | -0.98 | -1.04 | Lumos Pharma GAAP EPS of -$0.94 beats by $0.04, revenue of $0.4M beats by $0.38M [8/9/2022 4:02 PM] |
8.28 | 0.18 (2.22%) |
8.23 | 0.13 (1.60%) |
6.15 - 11.52 | 7,049 | 10,000 | 100 | |
| 10-05-2022 | AH | 4:00 PM ET (May 10) |
LUMO | Lumos Pharma, Inc. | 69.71 | -0.92 | -0.92 | -1.04 | Lumos Pharma GAAP EPS of -$0.92 misses by $0.02, revenue of $0.11M [5/10/2022 4:06 PM] |
7.90 | -0.15 (-1.86%) |
0.0 | 0.0 (0.00%) |
6.15 - 12.05 | 38,254 | 10,000 | 0 | |
| 10-03-2022 | AH | 4:00 PM ET (Mar 10) |
LUMO | Lumos Pharma, Inc. | 74.63 | -0.68 | -0.91 | -0.31 | Lumos Pharma GAAP EPS of -$3.65 beats by $0.24, revenue of $0.23M beats by $0.22M [3/10/2022 4:02 PM] |
8.87 | -0.65 (-6.82%) |
0.0 | 0.0 (0.00%) |
6.15 - 14.46 | 1,351 | 10,000 | 0 | |
|
||||||||||||||||||
| 03-11-2021 | AH | 4:00 PM ET (Nov 3) |
LUMO | Lumos Pharma, Inc. | 79.56 | -0.90 | -1.06 | 0.21 | Lumos Pharma EPS beats by $0.17 [11/3/2021 4:09 PM] |
9.83 | -0.21 (-2.09%) |
9.98 | -0.06 (-0.60%) |
7.23 - 36.72 | 22,496 | 10,000 | 585 | |
| 05-08-2021 | PM | Before the open (Aug 5) |
LUMO | Lumos Pharma, Inc. | 63.42 | -1.04 | -1.01 | -0.65 | Lumos Pharma EPS misses by $0.01 [8/5/2021 8:08 AM] |
7.54 | 0.04 (0.53%) |
0.0 | 0.0 (0.00%) |
7.33 - 36.72 | 74,038 | 180,000 | 0 | |
| 05-05-2021 | AH | 4:05 PM ET (May 5) |
LUMO | Lumos Pharma, Inc. | 103.15 | -1.04 | -0.85 | -0.14 | Lumos Pharma EPS misses by $0.17 [5/5/2021 4:22 PM] |
9.76 | -0.74 (-7.05%) |
10.67 | 0.17 (1.62%) |
8.98 - 36.72 | 43,288 | 30,000 | 2,100 | |
| 09-03-2021 | AH | 4:00 PM ET (Mar 9) |
LUMO | Lumos Pharma, Inc. | 108.61 | -0.31 | -0.85 | -1.98 | Lumos Pharma EPS beats by $0.57, beats on revenue [3/9/2021 4:07 PM] |
13.07 | 0.14 (1.08%) |
0.0 | 0.0 (0.00%) |
6.74 - 36.72 | 13,244 | 35,402 | 0 | |
| 10-11-2020 | AH | 4:00 PM ET (Nov 10) |
LUMO | Lumos Pharma, Inc. | 123.16 | 0.21 | -0.65 | -2.43 | Lumos Pharma EPS beats by $0.86, misses on revenue [11/10/2020 4:02 PM] |
14.36 | -0.20 (-1.41%) |
0.0 | 0.0 (0.00%) |
6.74 - 32.40 | 2,298 | 6,752 | 0 | |
|
|
||||||||||||||||||
| 13-08-2020 | AH | 4:00 PM ET (Aug 13) |
LUMO | Lumos Pharma, Inc. | 123.98 | -0.65 | -0.70 | -2.43 | Lumos Pharma EPS beats by $0.05 [8/13/2020 4:03 PM] |
15.00 | -0.41 (-2.66%) |
0.0 | 0.0 (0.00%) |
6.74 - 32.40 | 22,793 | 40,346 | 0 | |
|
|
||||||||||||||||||